{
      "Rank": 303,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Intranasal of 3 cc of conditioned medium each, for 3 days in a row and Intra-parenchymal transplantation of 20x10^6 UC-MSCs",
            "Intra-parenchymal transplantation of 20x10^6 UC-MSCs",
            "Neurologic and Neutrophic Drugs"
      ],
      "ArmGroupInterventionName": [
            "Biological: Conditioned Medium",
            "Biological: Umbilical Cord Mesenchymal Stem Cells",
            "Biological: Umbilical Cord Mesenchymal Stem Cells",
            "Procedure: Neurologic and Neutrophic Drugs"
      ],
      "ArmGroupLabel": [
            "Conditioned medium combined with Umbilical cord mesenchymal stem cells treatment",
            "Umbilical cord mesenchymal stem cells treatment",
            "Standard treatment (control)"
      ],
      "ArmGroupType": [
            "Experimental",
            "Experimental",
            "Active Comparator"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT05008588"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "The purpose of this study was to determine the effectiveness of a combination of intranasal conditioned medium (CM) with intraparenchymal umbilical cord mesenchymal stem cells (UC-MSCs) transplantation in acute stroke patients to induce neurogenesis."
      ],
      "BriefTitle": [
            "Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct"
      ],
      "CentralContactEMail": [
            "asct.prostem@gmail.com"
      ],
      "CentralContactName": [
            "Muhammad Agus Aulia"
      ],
      "CentralContactPhone": [
            "+6281283606327"
      ],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [
            "Contact"
      ],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "December 2023"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Ischemic Stroke"
      ],
      "ConditionAncestorId": [
            "D000002561",
            "D000001927",
            "D000002493",
            "D000009422",
            "D000014652",
            "D000002318"
      ],
      "ConditionAncestorTerm": [
            "Cerebrovascular Disorders",
            "Brain Diseases",
            "Central Nervous System Diseases",
            "Nervous System Diseases",
            "Vascular Diseases",
            "Cardiovascular Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC10",
            "BC14",
            "All",
            "BC23",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Nervous System Diseases",
            "Heart and Blood Diseases",
            "All Conditions",
            "Symptoms and General Pathology",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Ischemic Stroke",
            "Stroke"
      ],
      "ConditionBrowseLeafId": [
            "M2401",
            "M21459",
            "M9695",
            "M9434",
            "M4962",
            "M4356",
            "M4894",
            "M16552",
            "T170"
      ],
      "ConditionBrowseLeafName": [
            "Ischemic Stroke",
            "Stroke",
            "Ischemia",
            "Infarction",
            "Cerebrovascular Disorders",
            "Brain Diseases",
            "Central Nervous System Diseases",
            "Vascular Diseases",
            "Acute Graft Versus Host Disease"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000020521",
            "D000083242"
      ],
      "ConditionMeshTerm": [
            "Stroke",
            "Ischemic Stroke"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Factorial Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "This study has 3 arms namely CM and UC-MSCs treatment, UC-MSCs treatment only, and control. The investigator hypothesized that group of CM and UC-MSCs combination is the optimal treatment to induce neurogenesis in stroke patients."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nMale or female aged 25-60 years diagnosed with ischemic stroke acute phase\nThe patient has had a CT scan/MRI of the brain to assess ischemic territory\nThe patient must have an NIH Stroke score of 8-20\nThe patient or legal assistant has obtained detailed informed consent regarding the study protocol and agreeing to participate in the study\nPatients with The Glasgow Coma Scale (GCS) score > 8\nPatients with Pt-APTT values within normal limits\n\nExclusion Criteria:\n\nPatients with recurrent stroke in the 6 months preceding the episode current stroke\nCT or MRI images show midline shift and bleeding transformation\nParticipate in similar studies using CM and/or UC-MSC\nPatients who are immunocompromised and/or who are receiving therapy immunosuppressive\nPatients who cannot have a CT or MRI examination due to their condition\nPatients with impaired renal and hepatic function after the onset of ischemic stroke: Serum Glutamic Oxaloacetic Transaminase (SGOT) and Serum Glutamic Pyruvic Transaminase (SGPT) > 5x the upper limit of normal values and a significant increase in urea-creatinine values\nPatients with a history of malignant tumors or other severe neurologic conditions."
      ],
      "EnrollmentCount": [
            "15"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "Conditioned medium combined with Umbilical cord mesenchymal stem cells treatment",
            "Conditioned medium combined with Umbilical cord mesenchymal stem cells treatment",
            "Umbilical cord mesenchymal stem cells treatment",
            "Standard treatment (control)"
      ],
      "InterventionBrowseBranchAbbrev": [
            "PlAggInh",
            "All",
            "NootAg",
            "NeuroAg"
      ],
      "InterventionBrowseBranchName": [
            "Platelet Aggregation Inhibitors",
            "All Drugs and Chemicals",
            "Nootropic Agents",
            "Neuroprotective Agents"
      ],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [
            "M1669",
            "M5923",
            "M12932"
      ],
      "InterventionBrowseLeafName": [
            "Clopidogrel",
            "Cytidine Diphosphate Choline",
            "Piracetam"
      ],
      "InterventionBrowseLeafRelevance": [
            "low",
            "low",
            "low"
      ],
      "InterventionDescription": [
            "Intranasal of 3 cc of conditioned medium each, for 3 days in a row",
            "Intra-parenchymal transplantation of 20x10^6 UC-MSCs",
            "Such as clopidogrel, piracetam, citicoline"
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "Conditioned Medium",
            "Umbilical Cord Mesenchymal Stem Cells",
            "Neurologic and Neutrophic Drugs"
      ],
      "InterventionOtherName": [
            "Secretome",
            "Mesenchymal stromal cells"
      ],
      "InterventionType": [
            "Biological",
            "Biological",
            "Procedure"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "No"
      ],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Ischemic stroke",
            "Mesenchymal Stem Cells",
            "Conditioned Medium",
            "Secretome"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "September 26, 2022"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "September 23, 2022"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "PT. Prodia Stem Cell Indonesia"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Jakarta Pusat",
            "Jakarta"
      ],
      "LocationContactEMail": [
            "asct.prostem@gmail.com"
      ],
      "LocationContactName": [
            "Muhammad Agus Aulia, dr",
            "Muhammad Agus Aulia, dr"
      ],
      "LocationContactPhone": [
            "+6281283606327"
      ],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Contact",
            "Principal Investigator"
      ],
      "LocationCountry": [
            "Indonesia",
            "Indonesia"
      ],
      "LocationFacility": [
            "Gatot Soebroto Hospital",
            "PT Prodia StemCell Indonesia"
      ],
      "LocationState": [
            "DKI Jakarta"
      ],
      "LocationStatus": [
            "Recruiting",
            "Recruiting"
      ],
      "LocationZip": [
            "10410"
      ],
      "MaximumAge": [
            "60 Years"
      ],
      "MinimumAge": [
            "25 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Safety and Efficacy of Combined Conditioned Medium With Umbilical Cord Mesenchymal Stem Cells as A Novel Strategy for Acute Stroke Infarct"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "PT. Prodia Stem Cell Indonesia"
      ],
      "OrgStudyId": [
            "CT/STROKE/PSI/2021"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "Prodia StemCell Indonesia"
      ],
      "OverallOfficialName": [
            "Rima Haifa"
      ],
      "OverallOfficialRole": [
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Recruiting"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 1",
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "December 2023"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "Venous blood collection",
            "Venous blood collection",
            "To observe the brain development (neurogenesis)"
      ],
      "PrimaryOutcomeMeasure": [
            "Change from baseline Brain-Derived Neutrophic Factor at one month, 3 months and 6 months after transplantation",
            "Change from baseline Vascular endothelial growth factor at one month, 3 months and 6 months after transplantation",
            "Change baseline Magnetic Resonance Imaging at 6 month after transplantation"
      ],
      "PrimaryOutcomeTimeFrame": [
            "Before treatment, one month after treatment, 3 months after treatment, and 6 month after treatment",
            "Before treatment, one month after treatment, 3 months after treatment, and 6 month after treatment",
            "Before treatment, 6 month after transplantation"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "The NIH Stroke Scale (NIHSS) is a 15-item scale that is a well-validated and prognostically important measure of stroke-related neurologic deficits in research and clinical care",
            "The Modified Rankin Scale (mRS) is used to measure the degree of disability in patients who have had a stroke"
      ],
      "SecondaryOutcomeMeasure": [
            "The National Institute of Health Stroke Scale (NIHSS) Scoring",
            "modified Rankin Scale (mRS)"
      ],
      "SecondaryOutcomeTimeFrame": [
            "Before treatment, one month after treatment, 3 months after treatment, and 6 month after treatment",
            "Before treatment, one month after treatment, 3 months after treatment, and 6 month after treatment"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "May 30, 2022"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "September 2022"
      ],
      "StdAge": [
            "Adult"
      ],
      "StudyFirstPostDate": [
            "August 17, 2021"
      ],
      "StudyFirstPostDateType": [
            "Actual"
      ],
      "StudyFirstSubmitDate": [
            "August 1, 2021"
      ],
      "StudyFirstSubmitQCDate": [
            "August 9, 2021"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}